SUTRO BIOPHARMA, INC. (STRO) Total liabilities 2017–2025
SUTRO BIOPHARMA, INC. (STRO) total liabilities at each fiscal year-end, per SEC filings.
$306.3MFY2025 · since FY2017: $47.3M → $306.3M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | $306.3M | -10.6% |
| FY2024 | $342.6M | +6.7% |
| FY2023 | $321.1M | +69.1% |
| FY2022 | $189.9M | +113.7% |
| FY2021 | $88.8M | +43.2% |
| FY2020 | $62.1M | +5.9% |
| FY2019 | $58.6M | -36.0% |
| FY2018 | $91.6M | +93.8% |
| FY2017 | $47.3M | — |
Years the filer does not tag total liabilities directly are shown as reported total assets − reported shareholders’ equity at the same fiscal year-end.
Source: SEC XBRL filings · For reference only · Not investment advice